AKT1 and Familial prostate cancer: The results of KEGG enrichment analysis showed that SSA regulated pathways in cancer, proteoglycans in cancer, EGFR tyrosine kinase inhibitor resistance, the PI3K-AKT signaling pathway, and other signaling pathways to exert therapeutic effects in prostate cancer.